"10.1371_journal.pone.0023379","plos one","2011-09-06T00:00:00Z","Sandra L Dabora; David Neal Franz; Stephen Ashwal; Arthur Sagalowsky; Francis J DiMario; Daniel Miles; Drew Cutler; Darcy Krueger; Raul N Uppot; Rahmin Rabenou; Susana Camposano; Jan Paolini; Fiona Fennessy; Nancy Lee; Chelsey Woodrum; Judith Manola; Judy Garber; Elizabeth A Thiele","Biogen Idec Hemophilia, Weston, Massachusetts, United States of America; Massachusetts General Hospital, Boston, Massachusetts, United States of America; Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America; University of Cincinnati, Cincinnati, Ohio, United States of America; Loma Linda University, Loma Linda, California, United States of America; University of Texas Southwestern, Dallas, Texas, United States of America; University of Connecticut, Hartford, Connecticut, United States of America; New York University, New York City, New York, United States of America; Brigham and Womens Hospital, Boston, Massachusetts, United States of America","Conceived and designed the experiments: SD JM FF JG. Performed the experiments: DF SA AS FD DM DC DK RU RR SC JP NL CW ET. Analyzed the data: SD NL JM. Contributed reagents/materials/analysis tools: FF. Wrote the paper: SD.","Wyeth/Pfizer supplied study drug at no charge per an investigator originated proposal written by SD. SD has been a consultant to Novartis. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2011","09","Sandra L Dabora","SLD",18,TRUE,4,14,3,1,TRUE,TRUE,FALSE,0,NA,FALSE
